212 related articles for article (PubMed ID: 12819009)
1. Methylation target array for rapid analysis of CpG island hypermethylation in multiple tissue genomes.
Chen CM; Chen HL; Hsiau TH; Hsiau AH; Shi H; Brock GJ; Wei SH; Caldwell CW; Yan PS; Huang TH
Am J Pathol; 2003 Jul; 163(1):37-45. PubMed ID: 12819009
[TBL] [Abstract][Full Text] [Related]
2. Dissecting complex epigenetic alterations in breast cancer using CpG island microarrays.
Yan PS; Chen CM; Shi H; Rahmatpanah F; Wei SH; Caldwell CW; Huang TH
Cancer Res; 2001 Dec; 61(23):8375-80. PubMed ID: 11731411
[TBL] [Abstract][Full Text] [Related]
3. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
4. CpG island arrays: an application toward deciphering epigenetic signatures of breast cancer.
Yan PS; Perry MR; Laux DE; Asare AL; Caldwell CW; Huang TH
Clin Cancer Res; 2000 Apr; 6(4):1432-8. PubMed ID: 10778974
[TBL] [Abstract][Full Text] [Related]
5. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer.
Yan PS; Shi H; Rahmatpanah F; Hsiau TH; Hsiau AH; Leu YW; Liu JC; Huang TH
Cancer Res; 2003 Oct; 63(19):6178-86. PubMed ID: 14559801
[TBL] [Abstract][Full Text] [Related]
6. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.
Shames DS; Girard L; Gao B; Sato M; Lewis CM; Shivapurkar N; Jiang A; Perou CM; Kim YH; Pollack JR; Fong KM; Lam CL; Wong M; Shyr Y; Nanda R; Olopade OI; Gerald W; Euhus DM; Shay JW; Gazdar AF; Minna JD
PLoS Med; 2006 Dec; 3(12):e486. PubMed ID: 17194187
[TBL] [Abstract][Full Text] [Related]
7. Methylation-specific oligonucleotide microarray: a new potential for high-throughput methylation analysis.
Gitan RS; Shi H; Chen CM; Yan PS; Huang TH
Genome Res; 2002 Jan; 12(1):158-64. PubMed ID: 11779841
[TBL] [Abstract][Full Text] [Related]
8. An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells.
Holm K; Staaf J; Lauss M; Aine M; Lindgren D; Bendahl PO; Vallon-Christersson J; Barkardottir RB; Höglund M; Borg Å; Jönsson G; Ringnér M
Breast Cancer Res; 2016 Feb; 18(1):27. PubMed ID: 26923702
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia.
Gebhard C; Schwarzfischer L; Pham TH; Schilling E; Klug M; Andreesen R; Rehli M
Cancer Res; 2006 Jun; 66(12):6118-28. PubMed ID: 16778185
[TBL] [Abstract][Full Text] [Related]
10. Screening of significantly hypermethylated genes in breast cancer using microarray-based methylated-CpG island recovery assay and identification of their expression levels.
Lian ZQ; Wang Q; Li WP; Zhang AQ; Wu L
Int J Oncol; 2012 Aug; 41(2):629-38. PubMed ID: 22581028
[TBL] [Abstract][Full Text] [Related]
11. Microarray-based survey of CpG islands identifies concurrent hyper- and hypomethylation patterns in tissues derived from patients with breast cancer.
Piotrowski A; Benetkiewicz M; Menzel U; Díaz de Ståhl T; Mantripragada K; Grigelionis G; Buckley PG; Jankowski M; Hoffman J; Bała D; Srutek E; Laskowski R; Zegarski W; Dumanski JP
Genes Chromosomes Cancer; 2006 Jul; 45(7):656-67. PubMed ID: 16575877
[TBL] [Abstract][Full Text] [Related]
12. Methylation profiling of CpG islands in human breast cancer cells.
Huang TH; Perry MR; Laux DE
Hum Mol Genet; 1999 Mar; 8(3):459-70. PubMed ID: 9949205
[TBL] [Abstract][Full Text] [Related]
13. Expressed CpG island sequence tag microarray for dual screening of DNA hypermethylation and gene silencing in cancer cells.
Shi H; Yan PS; Chen CM; Rahmatpanah F; Lofton-Day C; Caldwell CW; Huang TH
Cancer Res; 2002 Jun; 62(11):3214-20. PubMed ID: 12036936
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation analysis using CpG microarrays is impaired in benzopyrene exposed cells.
Sadikovic B; Andrews J; Rodenhiser DI
Toxicol Appl Pharmacol; 2007 Dec; 225(3):300-9. PubMed ID: 17904174
[TBL] [Abstract][Full Text] [Related]
15. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM
Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038
[TBL] [Abstract][Full Text] [Related]
16. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic silencing of the candidate tumor suppressor gene PROX1 in sporadic breast cancer.
Versmold B; Felsberg J; Mikeska T; Ehrentraut D; Köhler J; Hampl JA; Röhn G; Niederacher D; Betz B; Hellmich M; Pietsch T; Schmutzler RK; Waha A
Int J Cancer; 2007 Aug; 121(3):547-54. PubMed ID: 17415710
[TBL] [Abstract][Full Text] [Related]
18. Differential methylation hybridization profiling identifies involvement of STAT1-mediated pathways in breast cancer.
Kim JH; Kang HS; Kim TW; Kim SJ
Int J Oncol; 2011 Oct; 39(4):955-63. PubMed ID: 21674123
[TBL] [Abstract][Full Text] [Related]
19. A microarray-based method for detecting methylated loci.
Hatada I; Kato A; Morita S; Obata Y; Nagaoka K; Sakurada A; Sato M; Horii A; Tsujimoto A; Matsubara K
J Hum Genet; 2002; 47(8):448-51. PubMed ID: 12181645
[TBL] [Abstract][Full Text] [Related]
20. Hypermethylation of the cpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers.
Dammann R; Yang G; Pfeifer GP
Cancer Res; 2001 Apr; 61(7):3105-9. PubMed ID: 11306494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
